About Us
   Programs
   Results
   Mission/Vision
   Leadership

Support Us

Research Awards
   About
   Impact
   Award Recipients
   Apply for an Award

Collaboration
   Clinical Network
   Preclinical Screening
   Industry

News Room
   What's New
   Advance Newsletter
   Releases
   In the News
   Media Kit

Resources/Information
   Learn from the Experts
   Statistics
   Clinical Trials
   Additional Resources

Contact Us

Home

Project Awards

2004

Investigator Institution Project

Tom Curran, PhD

 

St. Jude Children's
Research Hospital

 

Use of a novel SHH pathway inhibitor in human medulloblastoma

Russell Matthews, PhD

 

Yale University

 

Targeting a glioma-specific isoform of BEHAB/brevican for glioma therapy

William Pardridge, MD

 

University of California
Los Angeles

 

Non-viral polygenic gene therapy of brain cancer

Paul Mischel, MD

 

University of California
Los Angeles

 

Molecular analysis of glioblastoma for kinase inhibitor therapy

John Reed, MD, PhD

 

The Burnham Institute

 

IAP antagonists for glioblastoma

Jeremy Rich, MD

 

Duke University

 

Targeting non-mitogenic receptor kinases and intracellular mediators in glioma therapy

Rosalind Segal, MD, PhD

 

Dana-Farber Cancer
Institute

 

Therapeutic use of CXCR4 antagonists in glioblastoma

Paul Workman, PhD

 

Institute of Cancer Research UK

 

Mechanism of action of novel phosphatidylinositol 3-kinase inhibitors for use in glioblastoma therapy

Margaret Wrensch, PhD

 

University of California
San Francisco

 

Evaluation of SNPs from whole genome scans in relation to glioma prognosis

 
Content copyright © 2008 Accelerate Brain Cancer Cure, Inc.